Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 2
2005 2
2006 4
2007 3
2008 7
2009 2
2010 7
2011 1
2012 6
2013 3
2014 7
2015 5
2016 9
2017 10
2018 7
2019 5
2020 10
2021 21
2022 9
Text availability
Article attribute
Article type
Publication date

Search Results

108 results
Results by year
Filters applied: . Clear all
Page 1
Survival Outcomes Associated With 3 Years vs 1 Year of Adjuvant Imatinib for Patients With High-Risk Gastrointestinal Stromal Tumors: An Analysis of a Randomized Clinical Trial After 10-Year Follow-up.
Joensuu H, Eriksson M, Sundby Hall K, Reichardt A, Hermes B, Schütte J, Cameron S, Hohenberger P, Jost PJ, Al-Batran SE, Lindner LH, Bauer S, Wardelmann E, Nilsson B, Kallio R, Jaakkola P, Junnila J, Alvegård T, Reichardt P. Joensuu H, et al. Among authors: lindner lh. JAMA Oncol. 2020 Aug 1;6(8):1241-1246. doi: 10.1001/jamaoncol.2020.2091. JAMA Oncol. 2020. PMID: 32469385 Free PMC article. Clinical Trial.
[Hemato-oncological diseases].
Lindner LH, Hiddemann W. Lindner LH, et al. Internist (Berl). 2013 Oct;54(10):1197-204. doi: 10.1007/s00108-013-3291-y. Internist (Berl). 2013. PMID: 23989401 Review. German.
[Soft-tissue sarcoma: recent developments].
Lindner LH, Issels RD. Lindner LH, et al. Dtsch Med Wochenschr. 2012 Aug;137(31-32):1556-9. doi: 10.1055/s-0032-1305149. Epub 2012 Aug 7. Dtsch Med Wochenschr. 2012. PMID: 22872532 Review. German. No abstract available.
Nanomedicine-based strategies for treatment of atherosclerosis.
Schiener M, Hossann M, Viola JR, Ortega-Gomez A, Weber C, Lauber K, Lindner LH, Soehnlein O. Schiener M, et al. Among authors: lindner lh. Trends Mol Med. 2014 May;20(5):271-81. doi: 10.1016/j.molmed.2013.12.001. Epub 2014 Mar 1. Trends Mol Med. 2014. PMID: 24594264 Review.
A novel immune-related gene signature predicting survival in sarcoma patients.
Ren H, Bazhin AV, Pretzsch E, Jacob S, Yu H, Zhu J, Albertsmeier M, Lindner LH, Knösel T, Werner J, Angele MK, Bösch F. Ren H, et al. Among authors: lindner lh. Mol Ther Oncolytics. 2021 Dec 9;24:114-126. doi: 10.1016/j.omto.2021.12.007. eCollection 2022 Mar 17. Mol Ther Oncolytics. 2021. PMID: 35024438 Free PMC article.
Amputation for Extremity Sarcoma: Indications and Outcomes.
Kirilova M, Klein A, Lindner LH, Nachbichler S, Knösel T, Birkenmaier C, Baur-Melnyk A, Dürr HR. Kirilova M, et al. Among authors: lindner lh. Cancers (Basel). 2021 Oct 13;13(20):5125. doi: 10.3390/cancers13205125. Cancers (Basel). 2021. PMID: 34680274 Free PMC article.
Factors affecting drug release from liposomes.
Lindner LH, Hossann M. Lindner LH, et al. Curr Opin Drug Discov Devel. 2010 Jan;13(1):111-23. Curr Opin Drug Discov Devel. 2010. PMID: 20047152 Review.
Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection.
Banck JC, Mueller N, Mellinghoff SC, Thelen M, Fraccaroli A, Blumenberg V, Koehler P, Kunz WG, Rudelius M, Schrötzlmair F, Subklewe M, Schlößer HA, Tischer J, Cornely OA, Lindner LH, von Bergwelt-Baildon M. Banck JC, et al. Among authors: lindner lh. Hemasphere. 2021 Feb 10;5(3):e530. doi: 10.1097/HS9.0000000000000530. eCollection 2021 Mar. Hemasphere. 2021. PMID: 33604513 Free PMC article. No abstract available.
Hyperthermia in soft tissue sarcoma.
Lindner LH, Issels RD. Lindner LH, et al. Curr Treat Options Oncol. 2011 Mar;12(1):12-20. doi: 10.1007/s11864-011-0144-6. Curr Treat Options Oncol. 2011. PMID: 21360087 Review.
108 results